JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1989; 13:265-282
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hathaway, D.
Right arrow Articles by March, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hathaway, D.
Right arrow Articles by March, K.

Molecular cardiology: new avenues for the diagnosis and treatment of cardiovascular disease

DR Hathaway and KL March

Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis 46223.

This review summarizes some of the major advances in the investigation of molecular mechanisms underlying both normal and abnormal cardiovascular function. Four major areas are highlighted including cardiac muscle, the blood vessel, atherosclerosis and thrombosis/thrombolysis. The remarkable strides in understanding multifactorial diseases such as atherosclerosis, and the development of innovative new therapies such as the use of thrombolytic agents produced by recombinant deoxyribonucleic acid (DNA) technology, are noted. Moreover, it is concluded that the past decade of basic research has provided a solid framework for improvements in the diagnosis and therapy of other forms of cardiovascular disease as well. An evaluation of current trends in basic cardiovascular research suggests that diagnostic and therapeutic approaches to disease will increasingly target specific molecular processes underlying the pathophysiologic state.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
D. R. Elmaleh, J. Narula, J. W. Babich, A. Petrov, A. J. Fischman, B.-A. Khaw, E. Rapaport, and P. C. Zamecnik
Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates
PNAS, January 20, 1998; 95(2): 691 - 695.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale
THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action
J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. Narula, A. Petrov, C. Bianchi, C. C. Ditlow, B. C. Lister, J. Dilley, I. Pieslak, F. W. Chen, V. P. Torchilin, and B.-A. Khaw
Noninvasive Localization of Experimental Atherosclerotic Lesions With Mouse/Human Chimeric Z2D3 F(ab')2 Specific for the Proliferating Smooth Muscle Cells of Human Atheroma : Imaging With Conventional and Negative Charge–Modified Antibody Fragments
Circulation, August 1, 1995; 92(3): 474 - 484.
[Abstract] [Full Text]

Home page
 NEJMHome page
A. Maseri
Integration of Cellular and Molecular Biology with Clinical Research in Cardiology
N. Engl. J. Med., February 11, 1993; 328(6): 447 - 447.
[Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1989 by the American College of Cardiology Foundation.